mirvetuximab
immunogen
['mirasol', 'mirvetuximab', 'gyn', 'ovarian']
 new #asco23 study summary for patients: mirvetuximab soravtansine helps people with advanced, epithelial #ovarian, #fallopiantube, and #peritoneal cancers live longer #mirv #mirasol #gyncsm #ovariancancer
Timely, trusted, compassionate doctor-approved info from @ASCO. Signup https://t.co/2KibiNRMFU

We can't answer individual medical questions.

Retweet ≠Endorsement